Evaluating Choroidal Characteristics in Systemic Sclerosis Using Enhanced Depth Imaging Optical Coherence Tomography

REFERENCES

• Sakkas LI. New developments in the pathogenesis of systemic sclerosis. Autoimmunity. 2005;38:113–116.
   PubMed Web of Science ®Google Scholar
• Tailor R, Gupta A, Herrick A, et al. Ocular manifestations of scleroderma. Surv Ophthalmol. 2009;54:292–304.
   PubMed Web of Science ®Google Scholar
• Matucci-Cerinic M, Kahaleh B, Wigley FM. Review: evidence that systemic sclerosis is a vascular disease. Arthritis Rheum. 2013; 65:1953–1962.
   Google Scholar
• Farkas TG, Sylvester V, Archer D. The choroidopathy of progressive systemic sclerosis (scleroderma). Am J Ophthalmol. 1972;74:875–886.
   PubMed Web of Science ®Google Scholar
• Serup L, Serup J, Hagdrup H. Fundus fluorescein angiography in generalized scleroderma. Ophthalmic Res. 1987;19:303–308.
   PubMed Web of Science ®Google Scholar
• Kraus A, Guerra-Bautista G, Espinoza G, et al. Defects of the retinal pigment epithelium in scleroderma. Br J Rheumatol. 1991;30:112–114.
   PubMedGoogle Scholar
• Gherghel D, Orgul S, Dubler B, et al. Is vascular regulation in the central retinal artery altered in persons with vasospasm? Arch Ophthalmol. 1999;117:1359–1362.
   PubMedGoogle Scholar
• Hasler PW, Orgul S, Gugleta K, et al. Vascular dysregulation in the choroid of subjects with acral vasospasm. Arch Ophthalmol. 2002;120:302–307.
   PubMedGoogle Scholar
• Gugleta K, Orgül S, Hasler PW, et al. Choroidal vascular reaction to hand-grip stress in subjects with vasospasm and its relevance in glaucoma. Invest Ophthalmol Vis Sci. 2003;44:1573–1580.
   PubMed Web of Science ®Google Scholar
• Kim M, Kim SS, Kwon HJ, et al. Association between choroidal thickness and ocular perfusion pressure in young, healthy subjects: enhanced depth imaging optical coherence tomography study. Invest Ophthalmol Vis Sci. 2012;53:7710–7717.
   PubMed Web of Science ®Google Scholar
• Laviers H, Zambarakji H. Enhanced depth imaging-OCT of the choroid: a review of the current literature. Graefes Arch Clin Exp Ophthalmol. 2014; 252:1871–1883.
   Google Scholar
• Subcommittee for scleroderma criteria of the American Rheumatism Association. Diagnostic and Therapeutic Criteria Committee. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum. 1980;23:581–590.
   PubMed Web of Science ®Google Scholar
• LeRoy EC, Black C, Fleischmajer R, et al. Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol. 1988;15:202–205.
   PubMed Web of Science ®Google Scholar
• Dadaci Z, Doganay F, Oncel Acir N, et al. Enhanced depth imaging optical coherence tomography of the choroid in migraine patients: implications for the association of migraine and glaucoma. Br J Ophthalmol. 2014;98:972–975.
   PubMed Web of Science ®Google Scholar
• Bayhan HA, Aslan Bayhan S, İntepe YS, et al. Evaluation of the macular choroidal thickness using spectral optical coherence tomography in patients with obstructive sleep apnoea syndrome. Clin Experiment Ophthalmol. 2015;43:139–144.
   PubMed Web of Science ®Google Scholar
• Maclean H, Guthrie W. Retinopathy in scleroderma. Trans Ophthalmol Soc UK. 1970;89:209–220.
   PubMedGoogle Scholar
• Grennan DM, Forrester J. Involvement of the eye in SLE and scleroderma. A study using fluorescein angiography in addition to clinical ophthalmic assessment. Ann Rheum Dis. 1977;36:152–156.
   PubMed Web of Science ®Google Scholar
• Rapoport P, Merle H, Smadja D. Ischemic choroidopathy in primary Sjögren’s syndrome. Acta Ophthalmol Scand. 1998;76:627–628.
   PubMedGoogle Scholar
• Snyers B, Lambert M, Hardy JP. Retinal and choroidal vaso-occlusive disease in systemic lupus erythematosus associated with antiphospholipid antibodies. Retina. 1990;10:255–260.
   PubMed Web of Science ®Google Scholar
• Ingegnoli F, Gualtierotti R, Pierro L, et al. Choroidal impairment and macular thinning in patients with systemic sclerosis: the acute study. Microvasc Res. 2015;97:31–36.
   PubMed Web of Science ®Google Scholar
• Chizzolini C. Update on pathophysiology of scleroderma with special reference to immunoinflammatory events. Ann Med. 2007;39:42–53.
   PubMed Web of Science ®Google Scholar
• Campbell PM, LeRoy EC. Pathogenesis of systemic sclerosis: a vascular hypothesis. Semin Arthritis Rheum. 1975;4:351–368.
   PubMedGoogle Scholar
• Vancheeswaran R, Magoulas T, Efrat G, et al. Circulating endothelin-1 levels in systemic sclerosis subsets–a marker of fibrosis or vascular dysfunction? J Rheumatol. 1994;21:1838–1844.
   PubMed Web of Science ®Google Scholar
• Grieshaber MC, Mozaffarieh M, Flammer J. What is the link between vascular dysregulation and glaucoma? Surv Ophthalmol. 2007;52(Suppl 2):S144–S154.
   PubMed Web of Science ®Google Scholar
• Fuchsjäger-Mayrl G, Luksch A, Malec M, et al. Role of endothelin-1 in choroidal blood flow regulation during isometric exercise in healthy humans. Invest Ophthalmol Vis Sci. 2003;44:728–733.
   PubMed Web of Science ®Google Scholar
• Walker UA, Tyndall A, Czirják L, et al. Clinical risk assessment of organ manifestations in systemic sclerosis: a report from the EULAR scleroderma trials and research group database. Ann Rheum Dis. 2007;66:754–763.
   PubMed Web of Science ®Google Scholar
• Milenkovic S, Petrovic L, Risimic D, et al. Choroidal sclerosis in localized scleroderma (morphea en plaque). Ophthalmic Res. 2008;40:101–104.
   PubMed Web of Science ®Google Scholar
• Guthauser U, Flammer J, Mahler F. The relationship between digital and ocular vasospasm. Graefes Arch Clin Exp Ophthalmol. 1988;226:224–226.
   PubMed Web of Science ®Google Scholar
• Thompson AE, Shea B, Welch V, et al. Calcium-channel blockers for Raynaud’s phenomenon in systemic sclerosis. Arthritis Rheum. 2001;44:1841–1847.
   Google Scholar
• Smith CR, Rodeheffer RJ. Raynaud’s phenomenon: pathophysiologic features and treatment with calcium-channel blockers. Am J Cardiol. 1985;55:154B–157B.
   PubMed Web of Science ®Google Scholar
• Kahan A, Amor B, Menkes CJ. A randomised double-blind trial of diltiazem in the treatment of Raynaud’s phenomenon. Ann Rheum Dis. 1985;44:30–33.
   PubMed Web of Science ®Google Scholar